Suchergebnisse - "Bettencourt, Paulo"

PubPharm (6)

1

Spironolactone therapy in heart failure patients with chronic kidney disease

enthalten in: Clinical cardiology | 2009

von Lopes, R. | Lourenco, P. | Mascarenhas, J. | +2

CommentOn: Clin Cardiol. 2009 Jun;32(6):347-8. - PMID 19569078

2

The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failure

enthalten in: European journal of heart failure | 2009

von Lourenço, P. | Araújo, J. | Azevedo, A. | +2

3

Safety of spironolactone use in ambulatory heart failure patients

enthalten in: Clinical cardiology | 2008

von Lopes, R. | Lourenço, A. | Mascarenhas, J. | +2

CommentIn: Clin Cardiol. 2009 Jun;32(6):347-8. - PMID 19569078

4

The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure

enthalten in: European journal of heart failure | 2004

von Alvelos, M. | Ferreira, A. | Bettencourt, P. | +4

5

The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure

enthalten in: American heart journal | 2002

von Ferreira, A. | Bettencourt, P. | Pimenta, J. | +4

6

Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency

enthalten in: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology | 2002

von Pimenta, J. | Pereira, M. | Castro, A. | +4

1
[1]